Literature DB >> 2867684

Effect of selective muscarinic antagonists on peristaltic contractions in opossum smooth muscle.

R J Gilbert, W J Dodds.   

Abstract

In this study we examined the role of M1- and M2-muscarinic receptors in the mediation of circular smooth muscle esophageal contractions elicited by pharmacological cholinergic stimulation and during peristalsis in anesthetized opossums. Esophageal-body contractions were induced by bethanechol administration, whereas peristalsis was elicited by pharyngeal stroking or cervical vagal stimulation. Contractions were measured by a low-compliance manometric recording system. The incidence and amplitude of bethanechol-induced contractions were antagonized by 4-diphenylacetoxy-n-methylpiperidine (4-DAMP) and atropine but not pirenzepine. 4-DAMP and atropine caused an increased velocity, decreased amplitude, and preferential reduction of the incidence of primary peristaltic contractions in the proximal smooth muscle esophagus. During long-train vagal stimulation, intra-stimulus A-waves had a velocity similar to primary peristalsis, whereas poststimulus B-waves showed a velocity considerably faster than primary peristalsis. Short-train vagal stimulation produced a contraction sequence, termed an "S-wave," that had a velocity similar to that of the A-wave. At low doses 4-DAMP increased the velocity and decreased the amplitude of A-wave and S-wave contractions, and at high doses 4-DAMP abolished both the A-wave and S-wave contractions. B-wave contractions were minimally affected by 4-DAMP. Pirenzepine had no effect on contractions induced by swallows or vagal stimulation. We conclude that M2-muscarinic receptors mediate esophageal contractions in the circular smooth muscle during primary peristalsis and during A-waves and S-waves induced by vagal stimulation, and M1-receptors do not have any important role in the excitatory neural pathway to the esophagus.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2867684     DOI: 10.1152/ajpgi.1986.250.1.G50

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

Review 1.  Neuromuscular control of esophageal peristalsis.

Authors:  H Park; J L Conklin
Journal:  Curr Gastroenterol Rep       Date:  1999-06

Review 2.  Swallowing: neurophysiologic control of the esophageal phase.

Authors:  A J Miller
Journal:  Dysphagia       Date:  1987       Impact factor: 3.438

Review 3.  Muscarinic receptor regulation of the esophagus and lower esophageal sphincter.

Authors:  B Greenwood
Journal:  Dysphagia       Date:  1994       Impact factor: 3.438

4.  Cholinergic dysfunction in Shy-Drager syndrome: effect of the parasympathomimetic agent, bethanechol.

Authors:  R K Khurana
Journal:  Clin Auton Res       Date:  1994-04       Impact factor: 4.435

Review 5.  Central neural control of esophageal motility: a review.

Authors:  E T Cunningham; P E Sawchenko
Journal:  Dysphagia       Date:  1990       Impact factor: 3.438

6.  MLCK and PKC Involvements via Gi and Rho A Protein in Contraction by the Electrical Field Stimulation in Feline Esophageal Smooth Muscle.

Authors:  Sun Young Park; Jae Ho Shim; Mina Kim; Yih Hsiu Sun; Hyun Soo Kwak; Xiangmei Yan; Byung-Chul Choi; Chaeuk Im; Sang Soo Sim; Ji Hoon Jeong; In Kyeom Kim; Young Sil Min; Uy Dong Sohn
Journal:  Korean J Physiol Pharmacol       Date:  2010-02-28       Impact factor: 2.016

7.  The contractile deceleration point: an important physiologic landmark on oesophageal pressure topography.

Authors:  J E Pandolfino; E Leslie; D Luger; B Mitchell; M A Kwiatek; P J Kahrilas
Journal:  Neurogastroenterol Motil       Date:  2009-12-27       Impact factor: 3.598

8.  Cholecystokinin-induced contraction of opossum sphincter of Oddi. Mechanism of action.

Authors:  N Hanyu; W J Dodds; R D Layman; W J Hogan
Journal:  Dig Dis Sci       Date:  1990-05       Impact factor: 3.199

9.  Effect of cisapride, a new prokinetic agent, on esophageal motor function.

Authors:  R J Gilbert; W J Dodds; P J Kahrilas; W J Hogan; S Lipman
Journal:  Dig Dis Sci       Date:  1987-12       Impact factor: 3.199

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.